Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;27(5):273.e1-273.e4.
doi: 10.1016/j.jaapos.2023.07.006. Epub 2023 Sep 15.

Incidence and de novo mutation rate of Marfan syndrome and risk of ectopia lentis

Affiliations

Incidence and de novo mutation rate of Marfan syndrome and risk of ectopia lentis

Ricky Z Cui et al. J AAPOS. 2023 Oct.

Abstract

Purpose: To investigate the population-based incidence and de novo mutation rate of Marfan syndrome and risk of ectopia lentis.

Methods: Patients newly diagnosed with Marfan syndrome in Olmsted County, Minnesota, from January 1, 1976, through December 31, 2005, were identified through medical records review. Outcome measures were Marfan incidence, de novo mutation rate, risk of ectopia lentis.

Results: Marfan syndrome was identified in 17 patients during the 30-year period, yielding an incidence of 0.52 per 100,000 people/year (95% CI, 0.27-0.77). Mean age at diagnosis was 24.4 years (range, 1.7 year to 51.3 years). Nine patients (53%) were female. Of the 17, 5 (29%) were new mutations, with a calculated mutation rate of 3.8 ± 1.7 × 10-5. Four (24%) were diagnosed with ectopia lentis, including 3 at the time of their Marfan diagnosis. Of the 14 patients at risk for developing ectopia lentis after being diagnosed with Marfan syndrome, 1 (7%) developed it during a mean follow-up of 9 years (range, 0-6.4). Twelve (71%) were diagnosed with dilated ascending aorta during a mean follow-up of 13.2 years (range, 6.7 months to 28.9 years).

Conclusions: Incidence and de novo mutation rate of Marfan syndrome in this population-based cohort was higher than prior reports. Ectopia lentis, whose prevalence in North America has not been reported previously, occurred in approximately one-fourth of study patients and more commonly around the time of initial Marfan diagnosis.

PubMed Disclaimer

Figures

FIG 1.
FIG 1.
Age at diagnosis of Marfan syndrome in 17 patients from Olmsted County from 1976 to 2005.

References

    1. Judge DP, Dietz HC. Marfan’s syndrome. Lancet 2005;366:1965–76. - PMC - PubMed
    1. Groth KA, Hove H, Kyhl K, et al. Prevalence, incidence, and age at diagnosis in Marfan syndrome. Orphanet J Rare Dis 2015;10:153. - PMC - PubMed
    1. Gray JR, Bridges AB, Faed MJ, et al. Ascertainment and severity of Marfan syndrome in a Scottish population. J Med Genet 1994;31:51–4. - PMC - PubMed
    1. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981;245:54–63. - PubMed
    1. Rand-Hendriksen S, Lundby R, Tjeldhorn L,et al. Prevalence data on all Ghent features in a cross-sectional study of 87 adults with proven Marfan syndrome. Eur J Hum Genet 2009;17:1222–30. - PMC - PubMed